NCT04637698View on ClinicalTrials.gov

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

OH2 injection

Oncolytic Type 2 Herpes Simplex Virus

Trial Locations (1)

400000

Chongqing University Cancer Hospital, Chongqing

Sponsors
All Listed Sponsors
lead

Binhui Biopharmaceutical Co., Ltd.

INDUSTRY